Skip to main content
Erschienen in: Head and Neck Pathology 3/2011

01.09.2011 | Original Paper

Tenascin-C in Chronic Sclerosing Sialadenitis

verfasst von: Apostolos Epivatianos, Fotis Iordanidis, Dimitrios Andreadis, Savas Iordanidis, Athanasios Poulopoulos, Anastasios Markopoulos

Erschienen in: Head and Neck Pathology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Tenascin-C is an extracellular matrix glycoprotein that has been implicated in the development of fibrosis in certain chronic inflammatory/sclerosing conditions. This study was undertaken to expand our understanding of the processes involved in fibrosis that occurs in chronic sclerosing sialadenitis (CSS) by investigating the distribution of tenascin-C. Fifteen specimens of CSS with varying degrees of fibrosis and five normal submandibular glands were retrospectively examined immunohistochemically for the distribution of TNC. Linear deposition of TNC was found around collecting ducts in normal glands and around collecting ducts without surrounding fibrotic tissue in CSS; percentage incidences were not statistically different. In contrast, broader, band-like deposition of TNC was found in the fibrous tissue around collecting ducts in CSS with widespread degree of fibrosis compared to little or no fibrosis; the percentage incidence was statistically different. In addition, deposition of TNC was found around duct-like structures and extremely atrophic acini but, interestingly, however, was not found in fibrotic interlobular septa. The results of this investigation suggest that TNC is likely involved in the fibrosis that occurs around collecting ducts in CSS.
Literatur
1.
Zurück zum Zitat Seifert G. Tumor-like lesions of the salivary glands. The WHO classification. Path Res Pract. 1992;188:836–46.PubMed Seifert G. Tumor-like lesions of the salivary glands. The WHO classification. Path Res Pract. 1992;188:836–46.PubMed
2.
Zurück zum Zitat Harrison JD. Histology and pathology of sialolithiasis. In: Witt RL, editor. Salivary gland diseases. Surgical and medical management. New York, Stuttgart: Thieme; 2006. p. 71–8. Harrison JD. Histology and pathology of sialolithiasis. In: Witt RL, editor. Salivary gland diseases. Surgical and medical management. New York, Stuttgart: Thieme; 2006. p. 71–8.
3.
Zurück zum Zitat Seifert G, Donath K. On the pathogenesis of the Kuttner tumor of submandibular gland-analysis of 349 cases with sialadenitis of submandidular gland. HNO. 1977;25:81–92.PubMed Seifert G, Donath K. On the pathogenesis of the Kuttner tumor of submandibular gland-analysis of 349 cases with sialadenitis of submandidular gland. HNO. 1977;25:81–92.PubMed
4.
Zurück zum Zitat Harrison JD, Epivatianos A, Bhatia SN. Role of microliths in the aetiology of chronic submandibular sialadenitis: a clinicopathological investigation of 154 cases. Histopathology. 1997;31:237–51.PubMedCrossRef Harrison JD, Epivatianos A, Bhatia SN. Role of microliths in the aetiology of chronic submandibular sialadenitis: a clinicopathological investigation of 154 cases. Histopathology. 1997;31:237–51.PubMedCrossRef
5.
Zurück zum Zitat Teymoortash A, Tiemann M, Schrader C, et al. Transforming growth factor beta in chronic obstructive sialadenitis of human submandibular gland. Arch Oral Biol. 2003;48:111–6.PubMedCrossRef Teymoortash A, Tiemann M, Schrader C, et al. Transforming growth factor beta in chronic obstructive sialadenitis of human submandibular gland. Arch Oral Biol. 2003;48:111–6.PubMedCrossRef
6.
Zurück zum Zitat Teymoortash A, Mandic R, Schrader C, et al. Extracellular matrix molecules in chronic obstructive sialadenitis: an immunohistochemical and Western blot investigation. J Oral Sci. 2004;46:227–33.PubMedCrossRef Teymoortash A, Mandic R, Schrader C, et al. Extracellular matrix molecules in chronic obstructive sialadenitis: an immunohistochemical and Western blot investigation. J Oral Sci. 2004;46:227–33.PubMedCrossRef
7.
Zurück zum Zitat Epivatianos A, Zaraboukas T, Poulopoulos A, et al. Immunohistochemical study of fibroblasts and mast cells in chronic submandibular sialadenitis. Oral Dis. 2008;14:254–63. Epivatianos A, Zaraboukas T, Poulopoulos A, et al. Immunohistochemical study of fibroblasts and mast cells in chronic submandibular sialadenitis. Oral Dis. 2008;14:254–63.
8.
Zurück zum Zitat Harrison JD, Epivatianos A. Immunoprofile of Kuttner tumor (chronic sclerosing sialadenitis). Int J Surg Pathol. 2010;18:443–7.PubMed Harrison JD, Epivatianos A. Immunoprofile of Kuttner tumor (chronic sclerosing sialadenitis). Int J Surg Pathol. 2010;18:443–7.PubMed
9.
Zurück zum Zitat Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:39–48. Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14:39–48.
10.
Zurück zum Zitat Jones FS, Jones PL. The tenascin family of extracellular matrix glycoproteins: structure, function and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235–59.PubMedCrossRef Jones FS, Jones PL. The tenascin family of extracellular matrix glycoproteins: structure, function and regulation during embryonic development and tissue remodeling. Dev Dyn. 2000;218:235–59.PubMedCrossRef
11.
Zurück zum Zitat Jones PL, Jones FS. Tenascin-c in development and diseases: gene regulation and cell function. Matrix Biol. 2000;19:581–96.PubMedCrossRef Jones PL, Jones FS. Tenascin-c in development and diseases: gene regulation and cell function. Matrix Biol. 2000;19:581–96.PubMedCrossRef
12.
Zurück zum Zitat Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol. 2003;200:488–99.PubMedCrossRef Chiquet-Ehrismann R, Chiquet M. Tenascins: regulation and putative functions during pathological stress. J Pathol. 2003;200:488–99.PubMedCrossRef
13.
Zurück zum Zitat Young SL, Chang LY, Erickson HP. Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev Biol. 1994;161:615–25.PubMedCrossRef Young SL, Chang LY, Erickson HP. Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev Biol. 1994;161:615–25.PubMedCrossRef
14.
Zurück zum Zitat Imanaka-Yoshida K, Matsumoto K, Hara M, et al. The dynamic expression of tenascin-C and tenascin-X during early heart development. Differentiation. 2003;71:291–8.PubMedCrossRef Imanaka-Yoshida K, Matsumoto K, Hara M, et al. The dynamic expression of tenascin-C and tenascin-X during early heart development. Differentiation. 2003;71:291–8.PubMedCrossRef
15.
Zurück zum Zitat Booth C, Hamden P, Selby PJ, et al. Towards defining roles and relationship for tenascin-C and TGF beta in normal and neoplastic urinary bladder. J Pathol. 2002;198:359–68.PubMedCrossRef Booth C, Hamden P, Selby PJ, et al. Towards defining roles and relationship for tenascin-C and TGF beta in normal and neoplastic urinary bladder. J Pathol. 2002;198:359–68.PubMedCrossRef
16.
Zurück zum Zitat Chiquet M, Gelman L, Lutz R, et al. From mechanical mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta. 2009;1793:911–20.PubMedCrossRef Chiquet M, Gelman L, Lutz R, et al. From mechanical mechanotransduction to extracellular matrix gene expression in fibroblasts. Biochim Biophys Acta. 2009;1793:911–20.PubMedCrossRef
17.
Zurück zum Zitat Mekonnen GA, Ijzer J, Nederbragt H. Tenascin-C in chronic canine hepatitis: immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3 + cells. Vet Pathol. 2007;44:803–13.PubMedCrossRef Mekonnen GA, Ijzer J, Nederbragt H. Tenascin-C in chronic canine hepatitis: immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3 + cells. Vet Pathol. 2007;44:803–13.PubMedCrossRef
18.
Zurück zum Zitat El-Karef A, Yoshida T, Gobazza EC, et al. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol. 2007;211:86–94.PubMedCrossRef El-Karef A, Yoshida T, Gobazza EC, et al. Deficiency of tenascin-C attenuates liver fibrosis in immune-mediated chronic hepatitis in mice. J Pathol. 2007;211:86–94.PubMedCrossRef
19.
Zurück zum Zitat Makhlut HA, Stepniakowska J, Hoffman S, et al. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol. 1996;107:856–9.CrossRef Makhlut HA, Stepniakowska J, Hoffman S, et al. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts. J Invest Dermatol. 1996;107:856–9.CrossRef
20.
Zurück zum Zitat Kaarteenaho-Wiik R, Lakari E, Soini Y, et al. Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J Histochem Cytochem. 2000;48:1257–68.PubMedCrossRef Kaarteenaho-Wiik R, Lakari E, Soini Y, et al. Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J Histochem Cytochem. 2000;48:1257–68.PubMedCrossRef
21.
Zurück zum Zitat Nakatsuji S, Yamate J, Sakuma S. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial and chronic progressive nephropathy in aged rats. Vet Pathol. 1988;35:352–60.CrossRef Nakatsuji S, Yamate J, Sakuma S. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial and chronic progressive nephropathy in aged rats. Vet Pathol. 1988;35:352–60.CrossRef
22.
Zurück zum Zitat Utsunomiya H, Tilakaratne WM, Oshiro K, et al. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med. 2005;34:498–507.PubMedCrossRef Utsunomiya H, Tilakaratne WM, Oshiro K, et al. Extracellular matrix remodeling in oral submucous fibrosis: its stage-specific modes revealed by immunohistochemistry and in situ hybridization. J Oral Pathol Med. 2005;34:498–507.PubMedCrossRef
23.
Zurück zum Zitat Mason GI, Hamburger J, Matthews JB. Mast cells, extracellular matrix components, TGF β receptor expression in labial salivary glands in systemic sclerosis. Ann Rheum. 2000;59:185–9.CrossRef Mason GI, Hamburger J, Matthews JB. Mast cells, extracellular matrix components, TGF β receptor expression in labial salivary glands in systemic sclerosis. Ann Rheum. 2000;59:185–9.CrossRef
24.
Zurück zum Zitat Shrestha P, Sumitomo S, Ogata K, et al. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells. Eur J Cancer Oncol. 1994;30B(6):393–9. Shrestha P, Sumitomo S, Ogata K, et al. Immunoreactive tenascin in tumours of salivary glands: evidence for enhanced expression in tumour stroma and production by tumour cells. Eur J Cancer Oncol. 1994;30B(6):393–9.
25.
Zurück zum Zitat Sunardi-Widyaputra S, VanDamme B. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas. Pathol Res Pract. 1993;189:138–43. Sunardi-Widyaputra S, VanDamme B. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas. Pathol Res Pract. 1993;189:138–43.
26.
Zurück zum Zitat Furuse C, Cury PR, Araujo NS, et al. Immunoexpression of extracellular matrix proteins in human salivary gland development. Eur J Oral Sci. 2004;112:548–51.PubMedCrossRef Furuse C, Cury PR, Araujo NS, et al. Immunoexpression of extracellular matrix proteins in human salivary gland development. Eur J Oral Sci. 2004;112:548–51.PubMedCrossRef
27.
Zurück zum Zitat Sousa SO, Ferrazzo KL, Loyola AM, et al. Immunoprofile of Kuttner tumor (chronic sclerosing sialadenitis). Int J Surg Pathol. 2008;16:143–9.CrossRef Sousa SO, Ferrazzo KL, Loyola AM, et al. Immunoprofile of Kuttner tumor (chronic sclerosing sialadenitis). Int J Surg Pathol. 2008;16:143–9.CrossRef
28.
Zurück zum Zitat Dill-MacKey E. Chronic hepatitis in dogs. Vet Clin North Am Small Anim Pract. 1995;25:387–98. Dill-MacKey E. Chronic hepatitis in dogs. Vet Clin North Am Small Anim Pract. 1995;25:387–98.
29.
Zurück zum Zitat Spring J, Beck K, Chiquet-Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell. 1989;59:325–34.PubMedCrossRef Spring J, Beck K, Chiquet-Ehrismann R. Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments. Cell. 1989;59:325–34.PubMedCrossRef
30.
Zurück zum Zitat Prieto AL, Andersson-Fisone N, Crossin KL. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin. J Cell Biol. 1992;119:663–78.PubMedCrossRef Prieto AL, Andersson-Fisone N, Crossin KL. Characterization of multiple adhesive and counteradhesive domains in the extracellular matrix protein cytotactin. J Cell Biol. 1992;119:663–78.PubMedCrossRef
31.
Zurück zum Zitat Schnapp LM, Hatch N, Ramos DM, et al. The human integrin α8β1 functions as a receptor for tenascin, fibronectin and vitronectin. J Biol Chem. 1995;270:23196–202.PubMedCrossRef Schnapp LM, Hatch N, Ramos DM, et al. The human integrin α8β1 functions as a receptor for tenascin, fibronectin and vitronectin. J Biol Chem. 1995;270:23196–202.PubMedCrossRef
32.
Zurück zum Zitat Streuli C. Extracellular matrix remodeling and cellular differentiation. Curr Opin Cell Biol. 1999;11:634–40.PubMedCrossRef Streuli C. Extracellular matrix remodeling and cellular differentiation. Curr Opin Cell Biol. 1999;11:634–40.PubMedCrossRef
33.
Zurück zum Zitat Basbaum CB, Web Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 1996;8:731–8.PubMedCrossRef Basbaum CB, Web Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix degradation at the cell surface. Curr Opin Cell Biol. 1996;8:731–8.PubMedCrossRef
Metadaten
Titel
Tenascin-C in Chronic Sclerosing Sialadenitis
verfasst von
Apostolos Epivatianos
Fotis Iordanidis
Dimitrios Andreadis
Savas Iordanidis
Athanasios Poulopoulos
Anastasios Markopoulos
Publikationsdatum
01.09.2011
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 3/2011
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-011-0265-z

Weitere Artikel der Ausgabe 3/2011

Head and Neck Pathology 3/2011 Zur Ausgabe

American Academy of Oral and Maxillofacial Pathology 65th Annual Meeting, San Juan, Puerto Rico

Clinical Pathologic Conference Case 3: Nodular Fasciitis

American Academy of Oral and Maxillofacial Pathology 65th Annual Meeting, San Juan, Puerto Rico

Clinical Pathologic Conference Case 6: Infantile Myofibroma

American Academy of Oral and Maxillofacial Pathology 65th Annual Meeting, San Juan, Puerto Rico

Clinical Pathologic Conference Case 1: Wegener’s Granulomatosis

American Academy of Oral and Maxillofacial Pathology 65th Annual Meeting, San Juan, Puerto Rico

Clinical Pathologic Conference Case 2: Langerhans Cell Histiocytosis

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …